PMID-26275694 – AOD9604 Intra-articular Injection Rabbit OA
Kwon DR, Park GY, Lee SU. The effects of intra-articular injection of combined AOD9604 and hyaluronic acid on rabbit osteoarthritis model. Ann Clin Lab Sci. 2015;45(4):408-415.
Quick Reference
| Property | Value |
|---|---|
| PMID | 26275694 |
| DOI | — |
| Year | 2015 |
| Journal | Annals of Clinical and Laboratory Science |
| Study Type | Animal in vivo |
| Evidence Level | V |
| Sample | Rabbits with surgically induced osteoarthritis (n = multiple groups) |
| Peptide(s) Studied | AOD-9604 |
Key Findings
- Intra-articular injection of AOD9604 combined with hyaluronic acid (HA) was significantly more effective than either agent alone in a rabbit OA model
- The combination treatment reduced cartilage damage scores compared to HA alone, AOD9604 alone, and saline controls
- Improved gross morphological recovery of the joint surface was observed in the combination group
- AOD9604 alone showed some chondroprotective effects, suggesting an independent mechanism in joint tissue
- Histological analysis confirmed reduced cartilage degeneration and improved proteoglycan content in the combination group
Study Design
Osteoarthritis was surgically induced in rabbit knee joints via anterior cruciate ligament transection. After OA establishment, rabbits were randomized to receive intra-articular injections of: (1) AOD9604 alone, (2) hyaluronic acid alone, (3) AOD9604 + HA combination, or (4) saline control. Injections were administered weekly. Outcomes were assessed by gross morphology, histological grading (Mankin score), and cartilage thickness measurements.
Limitations
- Surgically induced OA in rabbits may not fully replicate the chronic degenerative process of human OA
- Relatively small sample sizes per group
- No long-term follow-up beyond the treatment period
- Mechanism by which AOD9604 exerts chondroprotective effects was not elucidated
- Single dosing regimen tested without dose optimization
Clinical Relevance
This study expands AOD9604's therapeutic profile beyond metabolic/obesity applications into musculoskeletal medicine. The synergy with hyaluronic acid is clinically relevant, as HA injections are already standard of care for OA. AOD9604 could potentially be added to existing HA protocols to enhance outcomes. This represents a repurposing opportunity that has gained interest in sports medicine and regenerative orthopedics.
Related
#research #animal-in-vivo #AOD-9604 #evidence-level-V